Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Oct;35(10):2521–2525. doi: 10.1128/jcm.35.10.2521-2525.1997

Rapid method for testing susceptibility of Mycobacterium tuberculosis by using DNA probes.

N Martin-Casabona 1, D Xairó Mimó 1, T González 1, J Rossello 1, L Arcalis 1
PMCID: PMC230003  PMID: 9316900

Abstract

The increasing number of multidrug-resistant Mycobacterium tuberculosis strains has stimulated the interest of investigators in finding a rapid method for susceptibility testing. We used commercially available rRNA DNA-bioluminescence-labelled probes (Accu-Probe, Gen Probe, Inc. San Diego, Calif.) for this purpose. The study was performed in three chronological steps. (i) We studied the correlation between the photometric light units (PLUs) given by the hybridization method, the numbers of CFU per milliliter, and turbidity as nephelometric units for six different inocula of an M. tuberculosis strain over 14 days. A good correlation (c > 0.9; P < 0.05) was found from the third day for all concentrations used. (ii) Over a period of 14 days we studied the evolution of the PLUs for 20 strains growing in medium with 0.2 microl of isoniazid (H) per ml and 18 strains in medium with 1 microl of rifampin (R) per ml to standardize the method. Susceptible and resistant strains were used according to the reference proportions method in Middlebrook 7H10, and the MICs were determined in solid and liquid media. The final inoculum of a 10(-2) dilution from a McFarland no. 1 standard and reading at 3 and 5 days provided the best results. A quotient was established to find a cutoff point between resistant and susceptible strains. (iii) We used the standardized parameters in 117 tests with H and R. On day 3, the sensitivity, specificity, positive predictive value, and negative predictive value for detecting resistant strains were 86.8, 100, 100, and 90.1%, respectively, and on day 5 they were 96.2, 100, 100, and 94%, respectively. We concluded that the method is readily available, is easy to perform, and could be useful for screening resistant M. tuberculosis strains.

Full Text

The Full Text of this article is available as a PDF (137.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bird B. R., Denniston M. M., Huebner R. E., Good R. C. Changing practices in mycobacteriology: a follow-up survey of state and territorial public health laboratories. J Clin Microbiol. 1996 Mar;34(3):554–559. doi: 10.1128/jcm.34.3.554-559.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cooksey R. C., Crawford J. T., Jacobs W. R., Jr, Shinnick T. M. A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agents Chemother. 1993 Jun;37(6):1348–1352. doi: 10.1128/aac.37.6.1348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Evans K. D., Nakasone A. S., Sutherland P. A., de la Maza L. M., Peterson E. M. Identification of Mycobacterium tuberculosis and Mycobacterium avium-M. intracellulare directly from primary BACTEC cultures by using acridinium-ester-labeled DNA probes. J Clin Microbiol. 1992 Sep;30(9):2427–2431. doi: 10.1128/jcm.30.9.2427-2431.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goto M., Oka S., Okuzumi K., Kimura S., Shimada K. Evaluation of acridinium-ester-labeled DNA probes for identification of Mycobacterium tuberculosis and Mycobacterium avium-Mycobacterium intracellulare complex in culture. J Clin Microbiol. 1991 Nov;29(11):2473–2476. doi: 10.1128/jcm.29.11.2473-2476.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jacobs W. R., Jr, Barletta R. G., Udani R., Chan J., Kalkut G., Sosne G., Kieser T., Sarkis G. J., Hatfull G. F., Bloom B. R. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science. 1993 May 7;260(5109):819–822. doi: 10.1126/science.8484123. [DOI] [PubMed] [Google Scholar]
  6. Kawa D. E., Pennell D. R., Kubista L. N., Schell R. F. Development of a rapid method for determining the susceptibility of Mycobacterium tuberculosis to isoniazid using the Gen-Probe DNA Hybridization System. Antimicrob Agents Chemother. 1989 Jul;33(7):1000–1005. doi: 10.1128/aac.33.7.1000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lebrun L., Espinasse F., Poveda J. D., Vincent-Levy-Frebault V. Evaluation of nonradioactive DNA probes for identification of mycobacteria. J Clin Microbiol. 1992 Sep;30(9):2476–2478. doi: 10.1128/jcm.30.9.2476-2478.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Miyamoto J., Koga H., Kohno S., Tashiro T., Hara K. New drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay. J Clin Microbiol. 1996 May;34(5):1323–1326. doi: 10.1128/jcm.34.5.1323-1326.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nilsson L. E., Hoffner S. E., Anséhn S. Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP. Antimicrob Agents Chemother. 1988 Aug;32(8):1208–1212. doi: 10.1128/aac.32.8.1208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rastogi N., Goh K. S., David H. L. Drug susceptibility testing in tuberculosis: a comparison of the proportion methods using Lowenstein-Jensen, Middlebrook 7H10 and 7H11 agar media and a radiometric method. Res Microbiol. 1989 Jul-Aug;140(6):405–417. doi: 10.1016/0923-2508(89)90016-8. [DOI] [PubMed] [Google Scholar]
  11. Siddiqi S. H., Hawkins J. E., Laszlo A. Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J Clin Microbiol. 1985 Dec;22(6):919–923. doi: 10.1128/jcm.22.6.919-923.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Snider D. E., Jr, Good R. C., Kilburn J. O., Laskowski L. F., Jr, Lusk R. H., Marr J. J., Reggiardo Z., Middlebrook G. Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):402–406. doi: 10.1164/arrd.1981.123.4.402. [DOI] [PubMed] [Google Scholar]
  13. Suo J., Chang C. E., Lin T. P., Heifets L. B. Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis strains isolated before treatment of patients in Taiwan. Am Rev Respir Dis. 1988 Oct;138(4):999–1001. doi: 10.1164/ajrccm/138.4.999. [DOI] [PubMed] [Google Scholar]
  14. Tarrand J. J., Gröschel D. H. Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis. J Clin Microbiol. 1985 Jun;21(6):941–946. doi: 10.1128/jcm.21.6.941-946.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Telenti A., Imboden P., Marchesi F., Lowrie D., Cole S., Colston M. J., Matter L., Schopfer K., Bodmer T. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet. 1993 Mar 13;341(8846):647–650. doi: 10.1016/0140-6736(93)90417-f. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES